Report : Middle East & Africa Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types (External Beam Radiation Therapy and Internal Beam Radiation Therapy) and Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer, and Others)
At 7.4% CAGR, Middle East & Africa Radiation Oncology Market is Projected to be Worth US$ 304.71 Million by 2031, says Business Market Insights
According to Business Market Insights' research, the Middle East & Africa radiation oncology market was valued at US$ 172.24 million in 2023 and is expected to reach US$ 304.71 million by 2031, registering a CAGR of 7.4% from 2023 to 2031. Increasing prevalence of cancer and strategic initiatives in radiation oncology are among the critical factors attributed to drive the Middle East & Africa radiation oncology market growth.
Cancer is one of the common health conditions significantly impacting society worldwide. According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, accounting for 9.7 million deaths and 20 million new cancer cases in 2022 and it is expected to reach ~35 million new cancer cases by 2050. As per the WHO 2024 report, lung cancer is the most common cancer and leading cause of the death globally followed by colorectal cancer, liver cancer, breast cancer, and stomach cancer accounting for 18.7%, 9.3%, 7.8%, 6.9%, and 6.8% of the total deaths respectively. Below mentioned are the incidence of top 10 cancers:
Figure 1. Statistics at Glance, Global, 2022
Cancer | Total New Cases, 2022 |
Lung | 2 480 675 |
Breast | 2 296 840 |
Colorectum | 1 926 425 |
Prostate | 1 467 854 |
Stomach | 968 784 |
Liver | 866 136 |
Thyroid | 821 214 |
Cervix Uteri | 662 301 |
Bladder | 614 298 |
NHL | 553 389 |
Source: Global Cancer Observatory
The increasing prevalence and incidence of cancer creates demand for effective treatment options. Radiotherapy is one of evolving treatment options for cancer patients with effective outcome which utilizes the high doses of radiation such as X-rays, gamma rays, and others to kill the cancerous cells. Radiotherapy is used in the early stages of cancer and various types of external beam radiotherapy are used for the treatment of different cancers. For instance, brachytherapy is used for the treatment of breast cancer, cervix cancer, eye cancer, prostate cancer, and head & neck cancer. Similarly, Systemic radiation therapy is also known as radioactive iodine and is used for treatment of thyroid cancer. Radiation therapy can be used at any point in the treatment and can be combined with other treatments such as surgery, chemotherapy, immunotherapy and others. Therefore, increasing prevalence of cancer and evolution of radiotherapy in oncology is expected to drive the growth of radiation oncology market.
On the contrary, high cost of radiotherapy equipment hampers the growth of Middle East & Africa radiation oncology market.
Based on types, the Middle East & Africa radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held 59.8% market share in 2023, amassing US$ 103.04 million. It is projected to garner US$ 178.65 million by 2031 to register 7.1% CAGR during 2023-2031.
By application, the Middle East & Africa radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held 44.0% share of Middle East & Africa radiation oncology market in 2023, amassing US$ 75.81 million. It is estimated to garner US$ 138.83 million by 2031 to expand at 7.9% CAGR during 2023-2031.
Based on country, the Middle East & Africa radiation oncology market is categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 34.8% share of Middle East & Africa radiation oncology market in 2023. It was assessed at US$ 59.96 million in 2023 and is likely to hit US$ 103.63 million by 2031, registering a CAGR of 7.0% during 2023-2031.
Key players operating in the Middle East & Africa radiation oncology market are Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, Panacea Medical Technologies Pvt. Ltd, and Curium, among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com